Trxade, Inc (MEDS) Corporate Media Kit

4 NASDAQ: MEDS • • Market Leader: Operates the largest technology platform serving the pharmaceutical supply chain (similar to eBay or Kayak-style platform) • Disruptive Innovation: Significantly lowering drug costs via a proprietary technology platform • Growing Rapidly: Grew revenues 94% in 2019 & added +3,200 pharmacies to a total of 11,725 • Profitable: Positive operating profits in 9 of the last 11 quarters with strong margins • Robust Balance Sheet: $4.2 million in cash with limited debt • Experienced Management: Management and Directors own ~54% of shares outstanding An Online Pharmaceutical Supply Chain Marketplace TRxADE is a technology & services company focused on a more effective process for purchasing and delivering prescription drugs to independent pharmacists & consumers About TRxADE Group, Inc. TRxADE Group, Inc. (NASDAQ: MEDS) Share Price 1 $5.52 Market Cap 1 $44.5M Revenues (TTM) 3 $12.8M Gross Margin (TTM) 3 48.5% Net Income (TTM) 3 $(0.8)M Q2 Adj. EBITDA 4 $501K Cash 2 $4.2M Debt 2 $0.2M Shares O/S 2 8.1M Float 2 3.7M Headquarters Land O’ Lakes, FL Management Ownership 2 54% 1) As of August 26, 2020. 2) As of the quarter ended June 30, 2020. 3) TTM = Trailing twelve months ended June 30, 2020. 4) Adj. EBITDA is a non-GAAP term, net income before interest, taxes, depreciation and amortization as well as share in equity loss on investment and stock-based compensation. See appendix for reconciliation to GAAP. Business to Business Robust procurement technology platform that delivers lower cost, more transparent fulfillment process for independent pharmacists compared to industry norms Business to Consumer Turnkey service through a retail mail order specialty pharmacy, wholesale operations as drugs are increasingly ordered & delivered directly to consumers